Cargando…

Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a ynthetic cannabinoid (SCB)

Synthetic Cannabinoids (SCB) are engineered chemical compounds that share a similar chemical structure with the active ingredient of marijuana, delta-9-tetrahydrocanabinol. Although the FDA has not approved the use of SCB without a prescription from a licensed health-care provider, the cost effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Parajuli, Priyanka, Regmi, Manjari Rani, Lara-Garcia, Odalys Estefania, Abu Limon, Ismael, Deckard, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427457/
https://www.ncbi.nlm.nih.gov/pubmed/32850099
http://dx.doi.org/10.1080/20009666.2020.1781349
_version_ 1783570881294893056
author Parajuli, Priyanka
Regmi, Manjari Rani
Lara-Garcia, Odalys Estefania
Abu Limon, Ismael
Deckard, Alan
author_facet Parajuli, Priyanka
Regmi, Manjari Rani
Lara-Garcia, Odalys Estefania
Abu Limon, Ismael
Deckard, Alan
author_sort Parajuli, Priyanka
collection PubMed
description Synthetic Cannabinoids (SCB) are engineered chemical compounds that share a similar chemical structure with the active ingredient of marijuana, delta-9-tetrahydrocanabinol. Although the FDA has not approved the use of SCB without a prescription from a licensed health-care provider, the cost effectiveness and availability of SCB has made it a popular choice among recreational drug users. Manufacture of SCB as a street drug is not regulated. These SCB are highly potent chemicals that cause various severe toxicities. In this case report, we describe an adult who suffered from PRES after consuming K2, a synthetic cannabinoid.
format Online
Article
Text
id pubmed-7427457
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-74274572020-08-25 Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a ynthetic cannabinoid (SCB) Parajuli, Priyanka Regmi, Manjari Rani Lara-Garcia, Odalys Estefania Abu Limon, Ismael Deckard, Alan J Community Hosp Intern Med Perspect Case Report Synthetic Cannabinoids (SCB) are engineered chemical compounds that share a similar chemical structure with the active ingredient of marijuana, delta-9-tetrahydrocanabinol. Although the FDA has not approved the use of SCB without a prescription from a licensed health-care provider, the cost effectiveness and availability of SCB has made it a popular choice among recreational drug users. Manufacture of SCB as a street drug is not regulated. These SCB are highly potent chemicals that cause various severe toxicities. In this case report, we describe an adult who suffered from PRES after consuming K2, a synthetic cannabinoid. Taylor & Francis 2020-08-02 /pmc/articles/PMC7427457/ /pubmed/32850099 http://dx.doi.org/10.1080/20009666.2020.1781349 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of Greater Baltimore Medical Center https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Parajuli, Priyanka
Regmi, Manjari Rani
Lara-Garcia, Odalys Estefania
Abu Limon, Ismael
Deckard, Alan
Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a ynthetic cannabinoid (SCB)
title Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a ynthetic cannabinoid (SCB)
title_full Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a ynthetic cannabinoid (SCB)
title_fullStr Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a ynthetic cannabinoid (SCB)
title_full_unstemmed Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a ynthetic cannabinoid (SCB)
title_short Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a ynthetic cannabinoid (SCB)
title_sort man vs. man-made marijuana: a case of drug-induced posterior reversible encephalopathy syndrome (pres) due to k2, a ynthetic cannabinoid (scb)
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427457/
https://www.ncbi.nlm.nih.gov/pubmed/32850099
http://dx.doi.org/10.1080/20009666.2020.1781349
work_keys_str_mv AT parajulipriyanka manvsmanmademarijuanaacaseofdruginducedposteriorreversibleencephalopathysyndromepresduetok2ayntheticcannabinoidscb
AT regmimanjarirani manvsmanmademarijuanaacaseofdruginducedposteriorreversibleencephalopathysyndromepresduetok2ayntheticcannabinoidscb
AT laragarciaodalysestefania manvsmanmademarijuanaacaseofdruginducedposteriorreversibleencephalopathysyndromepresduetok2ayntheticcannabinoidscb
AT abulimonismael manvsmanmademarijuanaacaseofdruginducedposteriorreversibleencephalopathysyndromepresduetok2ayntheticcannabinoidscb
AT deckardalan manvsmanmademarijuanaacaseofdruginducedposteriorreversibleencephalopathysyndromepresduetok2ayntheticcannabinoidscb